Corona Remedies Limited submitted a regulatory compliance certificate to BSE Limited and National Stock Exchange of India Limited regarding SEBI Regulation 74(5) requirements for the quarter ended June 30, 2026.
The certificate, received from Bigshare Services Private Limited (the company's Registrar to Issue and Share Transfer Agent), confirms that Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 is not applicable to the company for the specified quarter.
The non-applicability is due to two specific conditions: (1) the entire shareholding of the company remains in dematerialized form, and (2) the company did not receive any requests from shareholders for rematerialization or dematerialization during the quarter from March 31, 2026 to June 30, 2026.
The submission references SEBI circulars including NSDL/CIR/II/5/2019 dated January 25, 2019, CDSL/OPS/RTA/POLICY/2019/14 dated January 25, 2019, and SEBI letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated January 24, 2019.
The communication was signed by Chetna Prabhat Kumar Dharajiya, Company Secretary and Compliance Officer of Corona Remedies Limited, and digitally signed on July 06, 2026 at 14:46:50 IST.
Copies were also sent to National Securities Depository Limited and Central Depository Services (India) Limited for their records.